- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04030273
Prevalence of Intrauterine Adhesions After Abdominal Myomectomy
Uterine fibroids are the most common benign tumors of the genital organs of women of childbearing age. Literature data show that more than 75% of women have fibroids.Symptomatic fibroids account for approximately over 200,000 hysterectomies and 50,000 myomectomies annually in the United States. Fibroids have a major impact on fertility, with significant adverse effect on implantation rate and spontaneous abortion rates when compared with infertile women without fibroids. The definitive treatment for uterine fibroids in a fertile patient is surgical excision. Although usually effective, myomectomy is not a risk-free operation, since the surgical procedure can cause mechanical infertility and can be associated with infection, injury to adjacent tissues, hemorrhage and need to convert to hysterectomy. A not often mentioned consequence of myomectomy is post-operative intrauterine adhesion formation. It has been reported that 50% of women undergoing open myomectomy are found to have intrauterine adhesions diagnosed by hysteroscopy performed 3 months after surgery. Such a high prevalence of intrauterine adhesions after open myomectomy is unexpected, however only few studies have addressed this topic.
It is accepted that injury to the endometrium is generally considered to be the primary causative factor for the development of intrauterine adhesions. The reason for such a high incidence of intrauterine adhesions after open myomectomy is unclear. It is speculated that infection or in adverted closure of the uterine cavity may play a role in intrauterine adhesion formation. The relationship between the number of fibroids removed and the risk of adhesions suggests a traumatic etiology. In the preservation of the uterus for the purpose of fertility, it is essential to also understand the impact of myomectomy on the endometrium. Currently no guideline recommends in office hysteroscopy as follow-up after myomectomy. The purpose of the present study is to evaluate the frequency of uterine adhesions following myomectomy and the impact of number, size and location of the fibroids as well as intraoperative breach of the endometrial cavity at the time of the myomectomy.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Antonio Simone Laganà, M.D.
- Phone Number: +393296279579
- Email: antoniosimone.lagana@uninsubria.it
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosis of one or more uterine myomas
- Desire to preserve fertility/uterus
- Myomectomy (by laparotomy, laparoscopy or robotic approach).
Exclusion Criteria:
- Adults unable to consent
- Pregnant women
- Prisoners
- History of previous intrauterine procedures such as dilation and curettage
- History of known intrauterine adhesions
- History of documented pelvic inflammatory disease
- History of endometritis (acute or chronic)
- Hysteroscopic myomectomy
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Open (laparotomic) myomectomy
Women undergoing uterine myomectomy by open surgery (laparotomy).
|
Diagnostic hysteroscopy performed in outpatient setting, using "no touch" vaginoscopy technique with a 2.9 mm 30-degree rigid hysteroscope with a single inflow sheet using normal saline as distention media.
|
Laparoscopic myomectomy
Women undergoing uterine myomectomy by laparoscopy.
|
Diagnostic hysteroscopy performed in outpatient setting, using "no touch" vaginoscopy technique with a 2.9 mm 30-degree rigid hysteroscope with a single inflow sheet using normal saline as distention media.
|
Robotic myomectomy
Women undergoing uterine myomectomy by robotic surgery.
|
Diagnostic hysteroscopy performed in outpatient setting, using "no touch" vaginoscopy technique with a 2.9 mm 30-degree rigid hysteroscope with a single inflow sheet using normal saline as distention media.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intrauterine adhesions
Time Frame: 3 months after myomectomy
|
Presence of intrauterine adhesion, following the American Fertility Society classification (Fertil Steril.
1988;49:944-955.) in mild, moderate, or severe.
|
3 months after myomectomy
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Jose Carugno, University of Miami
- Study Chair: Andrea Tinelli, Vito Fazzi Hospital
- Study Chair: Antonio Simone Laganà, Università degli Studi dell'Insubria
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ADAM-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myoma;Uterus
-
Yonsei UniversityCompleted
-
Yonsei UniversityCompletedMyoma of UterusKorea, Republic of
-
Immunitor LLCUnknownLeiomyoma | Fibroma | Myoma;Uterus | Fibroid UterusMongolia
-
Universitaire Ziekenhuizen KU LeuvenRecruitingUltrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology (MUSA1)Myoma;Uterus | Sarcoma UterusBelgium
-
University Hospital, Clermont-FerrandActive, not recruitingMyoma;Uterus | Adenomyoma of UterusFrance
-
University of CagliariAzienda Ospedaliera Ordine Mauriziano di Torino; University of Foggia; Civic... and other collaboratorsRecruiting
-
Ciusss de L'Est de l'Île de MontréalCentre integre universitaire de sante et de services sociaux du Centre-Sud-de-l...Not yet recruitingMyoma;Uterus | Polyp UterusCanada
-
University Hospital, Clermont-FerrandRecruiting
-
Università degli Studi dell'InsubriaNot yet recruiting
-
Seoul National University HospitalJeysis MedicalNot yet recruiting
Clinical Trials on Diagnostic hysteroscopy
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Assaf-Harofeh Medical CenterSuspendedPlacenta; ImplantationIsrael
-
Sheba Medical CenterRecruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedHysteroscopy, Distension Medium, Pain
-
Centro Hospitalar Tondela-ViseuMarta Fernandes, M.D. MSc; Sonia Gonçalves, M.D; José Damasceno Costa, M.D.; Antonio... and other collaboratorsCompletedPelvic Girdle PainPortugal
-
Barzilai Medical CenterActive, not recruitingPrevenetion of Intrauterine Adhesions by Hyaluronic Acid GelIsrael
-
Università degli Studi dell'InsubriaCompletedBreast Cancer | Endometrial Cancer
-
Cairo UniversityUnknown
-
Assistance Publique - Hôpitaux de ParisCompleted